ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026
Maternal-Fetal Interplay During Mid-gestation: Inflammatory Biomarker Levels in Maternal Sera, Cord Sera and Placenta.
Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maternal-Fetal Interplay During Mid-gestation: Inflammatory Biomarker Levels in Maternal Sera, Cord Sera and Placenta.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
problemMaternal inflammation is linked to adverse maternal and fetal outcomes, but how maternal inflammation affects fetal inflammation during mid-gestation is not known. METHOD OF STUDY: We measured 20 biomarkers of inflammation, including chemokines, pro-and anti-inflammatory cytokines, and immunomodulatory cytokines, in matched maternal and cord sera and placental tissue collected during the second trimester from a diverse cohort (N = 106). We examined trends in biomarkers across the second trimester using a linear trend test, and compared distributions across sociodemographic groups using a Kruskal-Wallis test. We calculated Spearman correlation coefficients and stratified the correlation matrices by gestational age at sample collection (<20 vs. ≥ 20 gestational weeks).
resultsMost inflammatory biomarkers did not exhibit clear trends with gestational age, except for cord levels of CCL17 and CCL22; both Th2-associated chemokines significantly increased across the second trimester. There were no consistent patterns in biomarker levels across sociodemographic groups. Overall, correlations among maternal, placental and cord biomarkers were stronger before 20 weeks' gestation than in later pregnancy. While correlations between maternal and placental CCL17 declined after 20 weeks, the correlation between placental and cord CCL17 increased during this same period.
conclusionsMaternal and fetal inflammatory responses are more tightly coordinated earlier in the second trimester.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.